I must say I was a little uncertain about this cancer BTD, maybe I was reading too much basher post over there at liehub/ yahoo and I was trapped in the riddled Nader PRs. Until yesterday's explanation about how LL works with increased dosage regarding CTCs. It seems almost more logarithmic than linear efficiency increase regarding CTCs.
Beside a splendid safety profile, what else could FDA ask for an BTD application?